Biomaterials Market Size Worth $250.4 Billion by 2025 l CAGR: 14.7%: Grand View Research, Inc.
SAN FRANCISCO, January 8, 2019 /PRNewswire/ --
The global biomaterial market size is expected to reach USD 250.4 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 14.7% during the forecast period. Technological innovations in the field of biomaterials are leading to development of advanced products, which in turn is working in favor of the market. Widening base of geriatric population worldwide and subsequent rise in prevalence of cardiovascular and orthopedic disorders are providing a fillip to the market.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Biomaterials are now widely used in healthcare fields such as cardiovascular, orthopedic, dental, plastic medical procedure, wound repair, ophthalmology and neurological conditions. Furthermore, they are utilized in different advanced healthcare technologies such as cosmetic surgeries, tissue engineering, medical implants, and advanced drug delivery.
Geographically, North America held the largest share in the biomaterials market in 2017. The growth of the regional market can be attributed to various technological and mechanical progressions, high utility of medical services, growing geriatric population, and higher medical insurance coverage.
Some of the prominent companies operating in the market are DSM; BASF SE; Evonik Industries AG.; Berkeley Advanced Biomaterials, Inc.; CAM Bioceramics BV; Carpenter Technology Corporation; Invibio Ltd.; Zimmer Biomet Holdings, Inc.; Covalon Technologies Ltd.; Collagen Matrix, Inc.; Medtronic, Inc.; Purac Biomaterials; Ticona GmbH; Osteotech, Inc.; and Bayer AG.
Browse full research report with TOC on "Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Ceramics, Polymers), By Application (Cardiovascular, Orthopedics, Plastic Surgery), And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/biomaterials-industry
Further Key Findings From the Report Suggest:
- Rapid advancements in the field of genetics and increasing usage of biomaterials in oncology, personal genomics, and agrigenomics are expected to drive the market
- Factors such as high cost of instruments and platforms, ethical concerns, and ambiguous reimbursement policies in some countries are estimated to negatively impact the growth of the market
- Based on products, the natural segment is anticipated to register the highest CAGR of close to 16.7% during the forecast period
- On the basis of application, orthopedics was the most prominent segment in 2017, accounting for more than 20.0% of the market revenue
- There are many industrial scale healthcare projects and genome research projects launched in North American & European countries for improving the adoption of advanced healthcare technologies
- Strong presence of a raft of biomaterial technology providers, better infrastructure, patient awareness, and good healthcare facilities in these regions are aiding market growth.
Browse related reports by Grand View Research:
- White Biotechnology Market - The global white biotechnology market size was USD 203.28 billion in 2015.
- Proteomics Market - The global proteomics market was valued at over USD 11.8 billion in 2015.
- Next Generation Sequencing (NGS) Data Analysis Market - The Global Next Generation Sequencing (NGS) data analysis market was valued at USD 459.1 million in 2015.
- Therapeutic Drug Monitoring Market - The global therapeutic drug monitoring market was valued USD 1.77 billion in 2015.
Grand View Research has segmented the global biomaterials market based on products, application, technique, end use, and region:
- Biomaterials Products Outlook (Revenue, USD Million, 2014 - 2025)
- Metallic
- Natural
- Ceramics
- Polymers
- Biomaterials Application Outlook (Revenue, USD Million, 2014 - 2025)
- Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Vascular Grafts
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
- Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Others
- Orthopedic
- Joint Replacement biomaterials
- Orthobiologics
- Bioresorbable Tissue Fixation Products
- Viscosupplementation
- Spine Biomaterial
- Others
- Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
- Tissue Engineering
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold For CNS Repair
- Cortical Neural Prosthetics
- Others
- Others
- Cardiovascular
- Biomaterials Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East Africa
- South Africa
- North America
Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Share this article